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Background: Oestrogenic contaminants are widespread in the aquatic environment and have been shown to
induce adverse effects in both wildlife (most notably in fish) and humans, raising international concern. Available
detecting and testing systems are limited in their capacity to elucidate oestrogen signalling pathways and
physiological impacts. Here we developed a transient expression assay to investigate the effects of oestrogenic
chemicals in fish early life stages and to identify target organs for oestrogenic effects. To enhance the response
sensitivity to oestrogen, we adopted the use of multiple tandem oestrogen responsive elements (EREc38) in a Tol2
transposon mediated Gal4ff-UAS system. The plasmid constructed (pTol2_ERE-TATA-Gal4ff), contains three copies of
oestrogen response elements (3ERE) that on exposure to oestrogen induces expression of Gal4ff which this in turn
binds Gal4-responsive Upstream Activated Sequence (UAS) elements, driving the expression of a second reporter
gene, EGFP (Enhanced Green Fluorescent Protein).
Results: The response of our construct to oestrogen exposure in zebrafish embryos was examined using a transient
expression assay. The two plasmids were injected into 1–2 cell staged zebrafish embryos, and the embryos were
exposed to various oestrogens including the natural steroid oestrogen 17ß-oestradiol (E2), the synthetic oestrogen
17α- ethinyloestradiol (EE2), and the relatively weak environmental oestrogen nonylphenol (NP), and GFP expression
was examined in the subsequent embryos using fluorescent microscopy. There was no GFP expression detected in
unexposed embryos, but specific and mosaic expression of GFP was detected in the liver, heart, somite muscle and
some other tissue cells for exposures to steroid oestrogen treatments (EE2; 10 ng/L, E2; 100 ng/L, after 72 h
exposures). For the NP exposures, GFP expression was observed at 10 μg NP/L after 72 h (100 μg NP/L was toxic to
the fish). We also demonstrate that our construct works in medaka, another model fish test species, suggesting the
transient assay is applicable for testing oestrogenic chemicals in fish generally.
Conclusion: Our results indicate that the transient expression assay system can be used as a rapid integrated
testing system for environmental oestrogens and to detect the oestrogenic target sites in developing fish embryos.
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Decades of research have shown that a number of nat-
ural and man-made chemicals interfere with the endo-
crine system and can result in adverse health effects in
humans, mammals and fish [1-3]. Wildlife living in, or
closely associated with the aquatic environment have
been shown to be especially impacted by these so-called
endocrine-disrupting chemicals (EDCs), because our
freshwaters, estuaries and oceans act as sinks for chem-
ical discharges [4]. Oestrogenic EDCs in the environ-
ment are of particular concern. Endogenous oestrogens
are a group of closely related steroid hormones essential
in the development and functioning of the reproductive
system. Extensive work has been conducted on natural
(e.g. 17β-oestradiol) and synthetic oestrogens (e.g. 17α-
ethinyloestradiol from the contraceptive pill) and their
interactions in the vertebrate body, including their tissue
distributions, mechanisms of action and pathways of
elimination [5-7]. Furthermore, adverse effects of expos-
ure to environmental oestrogens have received consider-
able research attention in a number of animal species,
but this work is largely restricted to adults and juveniles
[6,8], and there has been little study of effects on
embryos. Nothing is known regarding the relative sensi-
tivities of the different cell types and tissues to
oestrogenic EDCs, or other contaminants, during em-
bryogenesis. Furthermore, in spite of the widespread
concern for EDCs in the aquatic environment, there are
very few bioassay systems that are sufficiently sensitive
for accurate prediction of adverse biological effects.
Moreover, conventional methods of EDCs detection such
as tissue culture [9] and in vitro techniques [10,11] are
limited in their capacity to elucidate oestrogen signalling
pathways and tissue specific physiological impacts.
Teleost fish have three oestrogen receptors (ER), ERal-
pha, ERbeta-1 and ERbeta-2, that show tissue specific
patterns of expression and function in adults [12-14].
The different ER subtypes are also widely expressed in
body tissues in early life stages, from embryos to young
larvae [15], suggesting crucial roles of these signalling
pathways in early development. Indeed, recently it was
found that knockdown of ER-beta2 in the zebrafish sup-
pressed normal development of the lateral line neuro-
mast cells [16]. Endogenous oestrogen receptors
activated by oestrogenic chemicals bind to oestrogen re-
sponse elements within regulatory regions of oestrogen-
responsive genes. Response elements are recognized by
nuclear transcription factors, including members of the
steroid/nuclear receptor super family that then, together
with various other regulatory factors mediate transcrip-
tion of the associated downstream genes [17].
The adopted model in this work, the zebrafish (Danio
rerio) has become one of the most commonly used ani-
mals for examining effects of aquatic pollutants [18].Furthermore, with the available genomic resources and
suitability of this species for molecular manipulations,
the zebrafish has been applied more widely for research
in developmental biology and understanding of disease
processes. The medaka (Oryzias latipes) is another
model species widely used in ecotoxicology research and
for the development of transgenic techniques. Many
studies have shown that early life stages of fish have the
greatest sensitivity to environmental contaminants and
effects on development in the zebrafish and medaka are
greatly facilitated by the fact that their embryos are
transparent. [19-21].
Use of tissue-specific promoters has become a power-
ful tool for studies on endogenous gene expression [22]
and to analyse the function of promoters [9,23-25] and
transgenic fish have become an established technique in
developmental analyses. This generally includes using a
specific promoter and a green fluorescent protein (GFP)
or a luciferase reporter gene. To improve the efficiency
of the sensitivity, tissue specificity and ease of generating
transgenic fish, various manipulated gene systems have
recently been introduced. One of these is the Gal4-UAS
system. This is now used widely for the over expression
of transgenes in various transgenic animals, including
zebrafish [26]. This system comprises a two-part expres-
sion system that utilises the yeast transcription activator
protein Gal4 and its target sequence UAS (Upstream
Activated Sequence), to which Gal4 binds to activate
gene transcription [27,28]. The Tol2 transposon system,
originally identified in the medaka [29], has recently
been used to enhance the success rate of DNA integra-
tion into the zebrafish genome [30,31]. This is illustrated
in the work of [30,32]) where used of Tol2 increased the
transgenesis rate of linear DNA from 5% to 50%.
Transgenic zebrafish have considerable potential for
use in aquatic ecotoxicology to screen and test for hor-
mone mimics and potentially to develop a more
advanced system for assessing health impacts of chemi-
cals. As a consequence there has been considerable ac-
tivity in a number of laboratories to develop transgenic
zebrafish as tools for screening and testing of chemicals
[33-36]. Transgenic fish have the advantage that tissue
specific effects of EDCs can be identified to allow for
more directed and detailed studies to inform on health
outcomes. However, it is time consuming, both to pro-
duce and maintain the stable transgenic lines. As a con-
sequence, a number of studies have investigated the use
of transient expression assays to examine the spatial and
temporal expression of reporter genes that are fused to
the regulatory regions of various genes in zebrafish
embryos [37,38]. To date, biosensor transgenic fish (TG
fish) have only been generated in the zebrafish and me-
daka, and such technology has not been applied widely
to other fish species. In theory, however, having
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would be possible to develop a functional ‘transient
assay’, by which vector DNA is transiently introduced
into the fish embryo, in almost any fish species where
the eggs produced can physically be injected, and thus
examine the effect of chemical exposure specifically in
those fish species.
To date, there have not been any reported transient
expression assays for the detection of oestrogenic EDCs.
The transient expression assay process normally involves
the injection of fertilised embryos with a construct and
followed by assaying of the response (e.g. GFP or Luci-
ferase) once the embryos/larvae have reached the desired
stage of development. A major advantage of the transi-
ent assay would be that the technique is applicable to a
variety of fish species for examining tissue, stage and
chemicals specific responses without the need to gener-
ate TG fish lines.
With a plan to develop a rapid and sensitive transient
expression assay system to evaluate the oestrogenic ac-
tivity of environmental chemicals in different fish
embryos, we utilised a Gal4ff-UAS system that incorpo-
rates a two-step signal amplification process and a syn-
thetic oestrogen responsive element with 3EREs. A
major aim in this initial work was to make a construct
that was highly responsive to oestrogenic EDCs. We
then examined the responsiveness of the oestrogen re-
sponse elements and tissue and stage specific responses
in zebrafish using a transient expression assay. Finally,
we tested our plasmid in another fish species, the me-
daka, to show that transient expression assay is suitableFigure 1 Construction of reporter gene vectors with an oestrogen res
BamHI and NotI sites of the plasmid pBR322 vector containing a Tol2 eleme
complex binds to specific DNA sequences called the oestrogen response e
Transcription is induced and messenger RNA is translated into protein. GAL
Fluorescent Protein), in this “two-step” activation process (Step 1: Oestroge
synthesis of GFP).for observation of effects of oestrogenic compounds in
other fish test species.
Results and discussion
Construction of reporter gene vectors with oestrogen
responsive promoters
In the sequence of results reported, we first developed a
novel transient assay system using a synthetic oestrogen
responsive element, Tol2 and Gal4-UAS systems and the
GFP reporter gene, responsive to environmental
oestrogen. We then investigated the functional capability
of this construct and response to a range of potent and
weak environmental oestrogens using a transient expres-
sion assay using green fluorescent microscopy in zebra-
fish embryos/larvae. Finally, we proofed our vector
system further in another fish species, the medaka.
The construct produced for detecting oestrogen is
shown in Figure 1. Specific primers of EREc38 were run
in PCR reactions to produce the EREs. The EREs were
38 base pair (bp) sequences that consisted of a 17-bp
inverted repeat 5’-CAGGTCA nnn TGACCTG-3’ fol-
lowed by an AT-rich sequence [39]. Other studies that
have made TG fish for screening of oestrogen chemicals
have used various (and different) promoters, including
for the following genes, vitellogenin (VTG) [34], chorio-
genin L (ChgL) [40] and aromatase B [41]. Legler et al.
(2000) [42] developed a transgenic zebrafish line that
expressed the reporter gene luciferase (LUC) for examin-
ing oestrogenic compounds. Although the construct they
used, pEREtata-LUC, was sensitive, luciferase is not as
stable as GFP. The luciferase half-life varies from 3 toponsive promoter. 3ERE, TATA and Gal4ff were inserted into the
nt. Xeno-oestrogens bind to and activate the ER. The homodimer
lement (ERE) within regulatory regions of oestrogen responsive genes.
4ff activates “UAS (Upstream Activated Sequence) – GFP (Green
n induces synthesis of GAL4ff protein, step 2: GAL4ff protein induces
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gene construct. Furthermore, measurement of luciferase
is a bioassay that requires tissue homogenisation. In con-
trast, GFP can be detected in living cells/organisms. The
use of GFP in intact fish also has advantages over use of
in vitro transfected cell cultures, because it allows for in-
tegration of toxicodynamic and toxicokinetic factors into
the response [44]. The constructs that have been used in
previous studies for developing oestrogen response sys-
tems, such as pEGFP-ChgL [45], pZVTG1-EGFP [34]
are also liver specific genes.
In a mammalian cell culture system, Sathya et al.
(1997) [39] showed that a construct with 3EREs pro-
duced an enhanced expression compared with 2EREs
and 4EREs, especially in response to the natural
oestrogen, oestrdaiol-17β (E2). We therefore similarly
adopted three copies of ERE in our construct. For the
transcriptional initiation, the TATA box sequence was
inserted at 158 bp upstream of the Gal4ff start codon
and the Tol2 transposon system was adopted to provide
a more efficient transient reporter analyses. After the se-
quential synthesis of five successive constructs, we gen-
erated a novel plasmid vector system, p3ERE-TATA-
Gal4ff containing, Tol2 and a poly A tail and employing
two steps for amplification of the signal (Figure 1) where
Gal4ff activates “UAS-GFP’. In the activation process,
the first step, binding of oestrogens to ER and subse-
quent binding to ERE, induces the synthesis of GAL4ff
protein and in the second step Gal4ff protein induces
synthesis of GFP. This two-step process allows amplifi-
cation of the resulting signal which, in theory, should
give rise to a more “sensitive” transient expression assay
system for detecting oestrogen chemicals than has been
developed previously. In our approach, we used Gal4ff
rather than the more commonly used Gal-VP16/UAS
system, because GAL4ff is reported to be less toxic than
GAL4-VP16 in zebrafish cells [46].
Induction of GFP in the zebrafish embryo transient
expression assay
In the transient microinjection studies, expression of
gene in zebrafish and medaka embryos was mosaic be-
cause the microinjected recombinant DNAs were not
integrated to all cells. We minimised this problem by
flanking the transgene with a Tol2 transposon and we
were then able to identify target tissues for oestrogens in
early life stages more effectively [31].
No differences in mortality rate were observed be-
tween both control and oestrogen chemical treated
groups (> 95% survival), with the exception for 100 μg
NP/L where the most embryos died by 24 hpf. The lack
of toxicity effects in zebrafish embryos at the exposure
concentrations adopted (with the exception of 100 ug
NP/L) compared very favourably with previouslyreported findings (e.g. Scholz and Gutzeit (2000) for EE2
[47] and Kishida et al. (2001) for E2 [48]).
GFP expression was seen at 24 h after exposure to EE2
(data not shown), albeit at low level, whereas there was
no GFP expression detected in the controls at this time.
There was stronger and more specific tissue GFP expres-
sion in EE2 treated embryos at 72 and 96 hpf, focused
mainly in the liver, muscle and heart and this was there-
fore adopted as the time period for assessing tissue spe-
cific effects of oestrogens in the transient assay.
At 72 and 96 hpf there was no GFP expression
detected in embryos in the unexposed controls (Figure 2,
Ai-Aiii, Additional file 1: Figure S1), but GFP expressing
cells were seen clearly after exposure to EE2 (Figure 2,
Ci–Diii, Additional file 1: Figure Bi-Bii). No specific GFP
expression was observed in the liver at the lowest expos-
ure concentration of EE2 (10 ng/L), but weak GFP ex-
pression signals were detected in the heart and somite
muscle for this exposure concentration (Figure 2, Bi-Biii).
GFP expression was most clearly seen in the higher EE2
exposures. For exposure to 100 ng EE2/L GFP was
detected in a feint and dispersed manner in the liver and
there was strong GFP expression in the heart and somite
muscle. GFP expression in the heart was confirmed by
the periodical contractile movement of the GFP expres-
sing cells with each heart beat in the live injected larvae.
Strong GFP expression was also observed in the anterior
somite muscles. For exposure to 1000 ng EE2/L, GFP
expression was induced strongly in the liver, somite
muscle and heart (Figure 2, Ci-Ciii). Moreover, many
GFP expressing cells were observed in the anterior lateral
part of the injected embryos (Figure 2, Di). The number
of cells expressing GFP appeared to be positively asso-
ciated with the concentration of the EE2 exposure
(Table 1). For the transgenic lines of zebrafish that have
now been developed, it has bee shown that oestrogenic
EDCs activate ERE in liver [34,42], forebrain [41], neuro-
mast [49], heart [36,49] and somite muscle [49] and this
is consistent with the expression patterns seen here our
transient assay.
Exposure to the natural steroid oestrogen, E2, resulted
in similar responses to that seen for EE2. No GFP ex-
pression was observed in unexposed controls (Figure 3,
Ai-Aiii). Similarly, no GFP expression was observed for
the lowest E2 exposure concentration (10 ng E2/L, data
not shown). No GFP expression was observed in the
liver at 100 ng E2/L, but it was seen in the muscle (so-
mite and cranial) and heart (Figure 3, Bi-Biii). Exposure
to 1000 ng E2/L strongly induced GFP expression in the
heart, otic vesicle and somite muscle and there were
some GFP expressing cells observed in the liver (Figure 3,
Ci-Ciii). With E2, as well as with EE2, the GFP signal
was also observed in the lateral line neuromast cells
albeit a lower frequency (Additional file 1: Figure S1,
Figure 2 Expression of GFP in zebrafish embryos in the transient expression assay using the mixture of the plasmid pERE-Gal4ff
containing the Tol2 transposase mRNA and the plasmid pUAS-GFP. Fertilised zebrafish eggs were microinjected at the 1–2 cell stages with
the mixture of two plasmids. Injected embryos were then exposed for up to 72 hour post-fertilisation (hpf) to 17α-ethinyloestradiol (EE2). These
embryos showed specific mosaic expression of the reporter. The injected embryos exposed to 1000, 100 and 10 ng/L of EE2 expressed GFP in
cells most strongly in the somite muscle, heart and liver (72 hpf). This experiment was run in duplicate and was repeated at least seven times.
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expression in the heart and somite muscle (Figure 3, Di-
Diii). The reason for weak GFP induction by NP might
be due to a lower sensitivity of early development stagesTable 1 Percentage of plasmid injected zebrafish expressing
oestrogens (at 72 hpf)
Control EE2 (ng/L)
1000 100
Liver 0 74.3% (223/300) 61.6% (185/300)
Heart 0 82.7% (248/300) 66.3% (199/300)
Muscle 13.3% (40/300) 90.3% (271/300) 78.3% (235/300)
Forebrain 33% (99/300) 0
Otic vesicle 19% (47/300) 26.3% (78/300) 16.6% (50/300)
lateral line neuromast 10% (32/300) 22.3% (67/300) 13% (39/300)to this chemical in the zebrafish, as has been suggested
previously [50]. In addition, it has been reported that NP
might be transformed in fish to less potent metabolites
[51,52]. These data indicate that different xeno-GFP in different body tissues after exposure to
E2 (ng/L) NP (μg/L)
10 1000 100 10
0 70.7% (212/300) 18.7% (56/300) 0
0 78% (234/300) 65% (195/300) 56% (168/300)
27.3% (82/300) 87% (261/300) 74% (222/300) 71.3% (214/300)
0 25.6% (77/300) 0 0
10.6% (32/300) 27% (81/300) 25.3% (76/300) 0
14.7% (44/300) 25.3% (76/300) 18% (54/300) 4%(12/300)
Figure 3 Comparison of detectable response concentrations for different oestrogen compounds in the zebrafish embryo transient
assay. Injected embryos were exposed for up to 72 h post-fertilisation to 17β-oestradiol (E2) and nonylphenol (NP) and fluorescence detected
using fluorescence microscopy (Leica DMI 4000 B). No GFP expression was observed in controls (A1-A3), but low level GFP expression occurred in
the liver for exposure to 1000 ng E2/L (C2) and high level GFP expression was detected in the somite muscle and heart at exposure
concentrations of 100 and 1000 ng E2/L. Weak GFP expression was also detected in the heart and somite muscle of embryos for exposure to
10 μg/L NP (D1-D3). Embryos exposed to the higher concentrations of NP (100 μg/L) died. This experiment was run in duplicate and was
repeated at least seven times.
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and therefore potentially different health effects.
To assess the consistency of transient expression of
GFP, we counted the number of GFP-positive embryos
for different tissues at 72 hpf. As shown in Table 1, for
controls no GFP expression was observed in the liver,
heart and forebrain, but weak GFP expression signals
were detected in some embryos in somite muscles
(13.3%) and the otic vesicle (16%). In contrast, in
injected embryos (72 hpf ), strong GFP expression oc-
curred in the muscle and heart on exposure to both EE2
and E2. This was also the case for the liver in injected
embryos exposed to both EE2 and E2: 74% for 1000 ng
EE2/L, 62% for 100 ng EE2/L and 71% for 1000 ng E2/L.For the forebrain, the proportion of embryos expressing
GFP were 33% and 26% for exposure to 1000 ng EE2/L
and 1000 ng E2/L, respectively. For the NP exposure, the
proportion of injected embryos showing GFP expression
in muscle was 71% and 56% for the heart.
In general, the expression of GFP appeared to show a
concentration-dependent response for exposure to the
test oestrogens, as quantified via western blotting. The
highest EE2 exposure group (1000 ng/L) indicated a
16.6-fold increase in GFP levels in whole embryos com-
pared with untreated controls. Exposure to 10 ng EE2/L
resulted in a 2.1-fold increase in GFP compared with the
control (Figure 4A). Exposure to E2 at 1000 ng/L
induced a 12.4-fold increase in GFP above controls and
Figure 4 Western blot analysis of 72 hour old embryos injected with the mixture of the plasmid pERE-Gal4ff containing the Tol2
transposase mRNA and the plasmid pUAS-GFP. Whole-body homogenate samples of 40 embryos exposed to 17β-oestradiol (E2), 17α-
ethinyloestradiol (EE2) and nonylphonol (NP) at various exposure concentrations (via the water) are shown. Western blot analysis showed no
detectable expression of GFP (Green fluorescent protein) in controls. The level of GFP expression was induced in a concentration dependent
manner for the various oestrogenic chemicals (EE2, E2 and NP). GFP expression level was quantified by using Image J (http://rsb.info.nih.gov/ij/
index/html). Error bars represent the standard deviation. This experiment was run in duplicate three times.
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NP/L (Figure 4B-C). For the highest exposures to EE2
and E2 (1000 ng/L), the level of GFP induction for EE2
was stronger than for E2, indicating that EE2 was more
potent than E2.
Assessments of the relative potencies of various envir-
onmental oestrogens in our transient assay were consist-
ent with those reported in the literature for other assays
systems, with EE2 being the most potent compound
compared with E2, NP and BPA. Legler et al. (2002) [33]
similarly reported that EE2 was the most potent (xeno)
oestrogen compared with E2, NP and di(2-ethylhexyl)
phthalate (DEHP) in their transgenic zebrafish assay.
Relative potency estimates for these chemicals however,
can vary depending on the assessment method. For ex-
ample EE2 was shown to be 1.25-fold more potent than
E2 in yeast-based in vitro assay [53] but had around a 30
times higher potency than E2 and E1 for VTG induction
(measured as a protein in the plasma or VTG mRNA in
the liver) in female zebrafish [54] in in vivo. Thorpe
et al. (2003) [55] using a VTG induction assay in vivo,
reported that EE2 was between 11 to 27 times more po-
tent than E2. The responses to oestrogen in our zebrafish
transient assay developed have shown it to be as sensi-
tive as some other widely used oestrogen detection sys-
tems in fish (e.g. VTG induction), and as sensitive as
available oestrogen responsive TG fish [35].
Induction of GFP in the medaka embryo transient
expression assay
To examine if our transient assay system was applicable
in other fish species, we assessed the response of GFP in
the medaka embryo (Figure 5). Medaka has four types of
pigment cells, namely melanophores, xanthophores, leu-
cophores and iridophores [56] that could interfere with
the detection of GFP. To avoid this, we imaged theembryos using normal light, green (GFP) and red (RFP).
This was done because pigment cells are auto-
fluorescent both in green and red spectra, and therefore
by overlaying the different images (blue as background)
we were able to distinguish the signal due to GFP. At 3
dpf, injected medaka embryos showed GFP expression
in the skin, whereas no GFP expression was detected in
the control (unexposed embryos). To enhance our ability
to see clear GFP responses in other tissues, we exposed
the injected embryos for 11 days. At this time, tissue
specific expression became obvious in the liver, heart,
gall bladder and somite (stage 40; [57]). Medaka showed
a lower level of expression of GFP in muscle compared
with zebrafish (See Figure. 2Ciii and Figure 5D, F) which
might be due to differences in the transgenesis efficiency
with Tol2 system between the two species (being lower
in medaka than in zebrafish [58]). However, the different
responses between the species may also be due to the
physiological and genetic differences between them.
GFP expression observed in the skin and gallbladder
in medaka was not observed in zebrafish, which might
suggest that oestrogen receptor expression varies be-
tween fish species or oestrogen receptor binding affin-
ities for different fish species might be different in the
different embryos, at least for these organs. Differences
between fish species have been shown for tissue distribu-
tion of ER subtypes as well as differences in ER affinities
for environmental oestrogens ([59-61]). We do not yet
know how the oestrogenic response pattern observed by
GFP expression is related to the expression of ERs. The
available literature suggests that ERs are expressed ubi-
quitously in the whole embryos both in zebrafish and
medaka with an elevated expression in the neuromast
cells in zebrafish [16,62]. Given this, the tissue specific
response of GFP to oestrogenes may be as a consequence
of the co-factors associated with ER signalling pathway.
Figure 5 Analysis of transient expression of GFP in response to oestrogens in medaka embryos. The plasmid pERE-Gal4ff containing the
Tol2 transposase mRNA and the plasmid pUAS-GFP were injected into 1–2 cell stage medaka embryos and the embryos were exposed to 17α-
ethynyloestradiol (100 ng EE2/L) via the water. No GFP expression was detected in controls. The injected medaka embryos exposed to EE2
showed strong GFP expression in the skin in the anterior region and in the body trunk (B). At 11 dpf, fish exposed to EE2 showed GFP expression
in the somite muscle, heart, liver and gall bladder (D, F, H and J).
Lee et al. BMC Biotechnology 2012, 12:32 Page 8 of 12
http://www.biomedcentral.com/1472-6750/12/32Conclusion
Despite the fact that transient expression analysis has
been used in various areas of developmental biology,
there has been no report using transient expression ana-
lysis for detection of oestrogen compounds. The vector
system we have developed and applied in a transientassay effectively detects oestrogenic responses in body
tissues. Furthermore, the transient assay system is as
sensitive as many of the available TG fish for detecting
oestrogens, in some cases considerably more so [63]
There are however, exceptions to this, where the most
sensitive TG fish developed have been shown to respond
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EE2/L (300 pM E2 (approximately 81 ng E2/L)) [33,35].
Drawbacks of the transient expression assay over TG
fish includes the fact that mosaicism can make it more
difficult to detect GFP expression in physically small tis-
sues such as lateral line neuromast.
Comparing our transient assay system with VTG in-
duction, a well established biomarker of oestrogen ex-
posure, the detection threshold for EE2 (as an example)
in zebrafish in vivo is 2 ng EE2/L [64]. Induction of VTG
in medaka and common carp hepatocytes in culture is
reported at 30 ng E2/L [65] and 0.01 μM E2 [66], re-
spectively. The EC50 concentration (half maximal effect-
ive concentration) for EE2 in the MCF-7 cell assay and
yeast-oestrogen screen (YES) from Folmar et al. (2002)
[67] is 0.017 nM (5 ng/L) and 0.29 nM (86 ng/L),
respectively.
The vector system developed detected oestrogenic
EDCs in both the zebrafish and medaka, indicating the
likely wide suitability for application to other fish spe-
cies. This system would be a particularly powerful tech-
nique for use in fish species with long generation times
and/or where there are other difficulties for generating
transgenic lines in those species. The transient expres-
sion assay further provides a novel in vivo system for in-
vestigating oestrogenic effects on embryo development
in fish.
Methods
DNA construct for developing a transient assay
The construct, called pTol2_3ERE-TATA-Gal4ff was
based on the sequence of EREc38 (EREc38 5’-CCAGG-
TCAGAGTGACCTGAGCTAAAATAACACATTCAG-3’)
published by Sathya et al. (1997) [39]. The construct was
generated by Polymerase Chain Reaction (PCR) using
primers (upstream primer CCAGGTCAGAGTGACCT-
GAGCTAAAATAACACATTCA GCC AGGTCAGAGTG
and downstream primer CTGAATGTGTTATTTTAGC-
TCAGG TCACTC TGACCTGGCTGAATGTGTTAT).
The following conditions were used for 8 PCR cycles :
denaturation at 96 °C for 1 min, annealing at 60 °C and
extension at 72 °C for 1 min. Multiple tandem copies of
EREc38 (nEREc38, where n=number of ERE copies) were
obtained by PCR. EREc38 oligomers were prepared by
restriction digestion of the 3ERE with SmaI. The reporter
gene vector pKS(+) was digested with XhoI and XbaI.
After obtaining the 3ERE fragment, a second fragment
called TATA was constructed following the same protocol,
using the following primers: (upstream primer GGCGT-
CGACTCTAGAGGGTATATAATAGAT CTGCGATCT-
AAGTAAGCTTGG downstream primer CGCGGGCCC-
GGCTTTACCAACAG TACCGGAATGCCAAGCTTA-
CTTAGATCG). TATA was digested with ApaI and SalI.
Gal4-ff (amplified by PCR using primers: upstream primerGCCGGGCCCGCCACCATGAAGCTA CTGCTGTC
TTCT downstream primer CGCGGTACCGATTAGT-
TACCCGGGAGC) was inserted into the vector which
already contained the 3ERE and TATA. The BamHI and
NotI fragments of p3ERE-TATA-Gal4ffwere inserted into
the BamHI and NotI sites of the plasmid pBR322 vector
[30], the latter containing the Tol2 transposon. The posi-
tive clones were confirmed by sequencing. The resulting
plasmid was designated as pTol2_3ERE-TATA-Gal4ff.
Fish maintenance and microinjection of embryos
with DNA
Zebrafish were maintained at 28 ± 1 °C under a 14 h
light/10 h dark photoperiod and were fed Tetramin dry
tropical flake food (Tetramin; Tetraweke, Melle, Ger-
many) twice a day. Fertilised zebrafish eggs were col-
lected within 20 minutes post-fertilisation. Medaka were
maintained at 28 °C on a 14:8 light:dark cycle. All adult
medaka in this study were fed Artemia twice a day. The
concentration of plasmid was 20 pg/nl and 0.05% phenol
red was added to make the solution visible. Under a dis-
secting microscope, fertilised eggs were placed in injec-
tion plate and eggs were microinjected with a syringe
into the centre of the cell over the yolk-cytoplasm
boundary. Embryos were microinjected at the 1–2 cell
stage with 2 nl DNA using a microinjector (INTRACEL,
PICOSPRITZERWIII). Some of the embryos were also
exposed to various chemicals as detailed below.
Chemicals
17α-ethinyloestradiol (≥98% purity). 17β-oestradiol (98%
purity), and 4-Nonylphenol (Acros Organics) were pur-
chase from Sigma Chemical Co. Ltd. The stock solutions
of EE2, E2 and NP were prepared in acetone and subse-
quently stored at 4 °C, until required for the exposures.
The working solutions were prepared 3 days before use
in the exposures. Prior to exposure, the solvent was eva-
porated under a stream of nitrogen and the working
solutions made up with water and stirred vigorously for
1 day. The nominal concentration of treatment solutions
were: 17α-ethinyloestradiol (EE2): 1000 ng/L, 100 ng/L
and 10 ng/L; 17β-oestradiol (E2): 1000 ng/L, 100 ng/L and
10 ng/L; 4-Nonylphenol (NP): 100 μg/L and 10 μg/L Che-
micals were dissolved in embryo culture water. Fifty
embryos per chemical concentration were exposed for
up to 72 hours at 28 °C. All experiments were run in
duplicate and were repeated at least seven times.
The transient expression assay using fluorescent
microscopy detection
The plasmid pTol2_ERE-TATA-Gal4ff was mixed in a
1:1 ratio with the plasmid pTol2_UAS-GFP and then
mixed with transposase mRNA in a ratio of 1:2. The
mixture was microinjected (20 pg/nl) into 1–2 cell stage
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cultured for up to 72 hours (zebrafish) with and without
exposure to E2, EE2 and NP, and GFP expression exam-
ined by fluorescence microscopy (Leica DMI 4000 B). In
the studies with medaka, the plasmid pTol2_ERE-TATA-
Gal4ff with transposase mRNA was mixed in a 1:1 ratio
with the plasmid pTol2_UAS-GFP and this was then
injected into 1–2 cell stage medaka embryos (20 pg/nl).
Injected medaka eggs were exposed to EE2 (100 ng/L)
and embryo culture water for 11 days at 28 °C (±1 °C).
GFP expression was observed under a fluorescent micro-
scope (NIKON SMZ1500).
Synthesis of transposase mRNA
Transposase mRNA was synthesised in vitro using pCS-
TP which carries Tol2 transposase cDNA. The plasmid
pCS-TP was digested with NotI and purified by phenol:
chloroform extraction and ethanol precipitation. RNA
synthesis was performed using mMessage mMachine
SP6 kit (Ambion). The synthesized mRNA was purified
with Quick spin column for radiolabeled RNA purifica-
tion (Roche), purified by phenol: chloroform extraction
and by the subsequently ethanol precipitated. The RNA
precipitated was suspended in distilled water and used
for co-microinjection with pTol2_ERE-TATA-Gal4ff.
Western blot analysis
Western blot analysis was employed to quantify GFP ex-
pression. Embryos were transferred to a 1.5 ml tube
filled with lysis buffer (2x LDS (Lithium dodecyl sulfate)
sample buffer (Invitrogen), 2-Mercapto ethanol and dis-
tilled water), incubated at 95 °C for 5 minutes and the
vessel tapped to get them to the bottom of tube. Samples
were homogenised five times and centrifuged for 1 min
at 1000 rpm. Protein samples were applied to 5%
polyacrylamide-SDS gel and subjected to electrophoresis
at 110 V for 2 hour and separated proteins were trans-
ferred to nitrocellulose membrane. The membranes were
blocked for 1 hour in blocking solution (5% skimmed
milk in 1x phosphate buffered saline (PBS) + 0.1% Tween
(PBSTx)), and washed three times with distilled water
(ddH2O). The membranes were incubated overnight at
4 °C with primary antibody, rabbit anti-GFP (ams Biote-
chonology), diluted 1:2500 in blocking solution. The
membranes were washed for 3 x 15 minutes in PBSTx.
The membranes were incubated with HRP-Goat Anti-
Rabbit IgG (Invitrogen, Carlsbad, U.S.A) at 1:2000 in
blocking solution for 2 hours and then washed 3 x 15
minutes in PBSTx again. For detection, Western blotting
luminol reagent (Thermo Scientific) was used. The in-
tensity of GFP was analysed using Image J (http://
rsbweb.nih.gov/ij/), normalised to the intensity of alpha-
tubulin band and indicated as fold increase in GFP over
the level in control larvae.Statistical analysis
All data are reported as mean ± SEM. Statistical evalu-
ation were performed using Student’s t-test and the com-
parison between controls and each exposed groups.
Statistical significance is indicated at the p <0.05 level.
Additional file
Additional file 1: Figure S1 GFP expression at 4 dpf embryos in the
transient expression assay. Injected embryos without chemical exposure
(A) or exposed to the oestrogenic chemicals 17α-ethinyloestradiol (1000
ngEE2/L) (B), 17β-oestradiol (1000 ng E2/L) (C) and nonylphonol (10 μgNP/L)
(D) for 4 days. Head with lateral (L) and ventral (V) views (i and ii) and trunk
with lateral view (iii). The shape of the liver is outlined with a white line. No
GFP expression was observed in the unexposed control (A). EE2 and E2
induced GFP expression in the heart (h), liver (li), neuromasts (n) and somite
muscles (sm) (B,C). In NP exposed larvae, GFP expression was observed
mainly in the muscle and heart (D).
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